Results 41 to 50 of about 8,024,802 (308)

Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant

open access: yesHepatology, 2021
There are no prospective data on stereotactic body radiation therapy (SBRT) as a bridge to liver transplantation for HCC. This study aimed to evaluate the efficacy and safety of SBRT as bridging therapy, with comparison with transarterial ...
T. Wong   +17 more
semanticscholar   +1 more source

Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience

open access: yesClinical and Translational Radiation Oncology, 2023
Highlights • Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT)• MRgSBRT with optional adaptation can deliver ablative doses to primary liver cancer.• Adaptation was associated with having radiation targets ≤ 1 cm of organs at risk.•
R. Chin   +14 more
semanticscholar   +1 more source

Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

open access: yesJournal of the American Medical Association (JAMA), 2010
Context Patients with early stage but medically inoperable lung cancer patients have a poor rate of primary tumor control (30-40%) and a high rate of mortality (3-year survival 20-35%) with current management.
R. Timmerman   +12 more
semanticscholar   +1 more source

The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)

open access: yesCancers, 2022
Simple Summary The role of stereotactic body radiotherapy (SBRT), which can deliver high radiation doses to focal tumors, has greatly increased in not only early-stage hepatocellular carcinoma (HCC), but also in portal vein or inferior vena cava thrombi,
T. Kimura   +4 more
semanticscholar   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done

open access: yesCancers, 2022
Simple Summary Adoption of single-fraction stereotactic body radiation therapy for lung tumors has been limited among different institutions even during the coronavirus disease 2019 (COVID-19) pandemic. Potential reasons may include a lack of familiarity
A. Bartl   +9 more
semanticscholar   +1 more source

Stereotactic Body Radiation Therapy for Spinal Metastases [PDF]

open access: yes, 2022
SBRT for Spinal Metastases Kendall Pearage Dr. Gina Capitano Ed. D, R.T. (R) Cathy Moody R.T. (T) Northeast Radiation Oncology Center Abstract Spinal metastases are the most common spinal tumors accounting for approximately 90% of cases and are a result ...
Pearage, Kendall
core   +1 more source

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac

open access: yesAdvances in Radiation Oncology, 2022
Purpose Adaptive stereotactic body radiation therapy (SBRT) for prostate cancer (PC) by the 1.5 T MR-linac currently requires online planning by an expert user.
S. Naccarato   +18 more
semanticscholar   +1 more source

Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)

open access: yesClinical and Translational Radiation Oncology, 2020
Background: There is increasing interest in treating oligometastatic non-small cell lung cancer (NSCLC) patients with stereotactic radiation. We aimed to address whether patients definitively treated with synchronous thoracic stereotactic body radiation ...
John Nikitas   +7 more
doaj   +1 more source

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation

open access: yesAdvances in Radiation Oncology, 2020
Purpose Patients with inoperable pancreatic adenocarcinoma have limited options, with traditional chemoradiation providing modest clinical benefit and an otherwise poor prognosis.
C. Hassanzadeh   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy